Journal of clinical gastroenterology
Clostridioides difficile Infection Is Associated With Increased Colectomy Risk in Acute Severe Ulcerative Colitis Treated With Infliximab.
Tamara F Kahan, Olivia Delau, Simon Hong, Ariela Holmer, John Dodson, Aasma Shaukat, Joshua Chodosh, David Hudesman, Jordan E Axelrad, Adam S Faye
Published: 202510.1097/MCG.0000000000002276
Abstract
BACKGROUND: Infliximab (IFX) is commonly used in the management of acute severe ulcerative colitis (ASUC), yet up to 30% of individuals still require colectomy within 1 year. Clinical data characterizing these patients, however, are limited. AIMS: We…
Preview only. Read the full abstract at the source